OpenAI GPT-Rosalind-6 Research: frontier biology and drug-discovery model for approved organizations

OpenAI published the GPT-Rosalind-6 system card addendum on October 30, 2026: a frontier reasoning model for biology, drug discovery and translational medicine, offered as GPT-Rosalind-6 Research to qualified scientists and organizations through trusted access with fewer refusals on dual-use biology questions.